Table 3.
CPFE group (n=11) | Emphysema group (n=108) | IP group (n=7) | Normal group (n=124) | P-value | |
---|---|---|---|---|---|
Pneumonia | 1 (9.0%) | 2 (1.8%) | 1 (14.2%) | 0 (0%) | 0.004 |
ALI | 0 (0%) | 4 (3.7%) | 1 (14.2%) | 2 (1.6%) | 0.197 |
Prolonged mech vent | 1 (9.0%) | 2 (1.8%) | 1 (14.2%) | 0 (0%) | 0.004 |
HOT | 1 (9.0%) | 1 (0.9%) | 0 (0%) | 0 (0%) | 0.014 |
30-day mortality | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1.000 |
90-day mortality | 1 (9.0%) | 3 (2.7%) | 0 (0%) | 0 (0%) | 0.064 |
Causes of death | |||||
Primary cancer | 4 (36.4%) | 16 (14.8%) | 1 (14.2%) | 12 (9.6%) | 0.08 |
Respiratory failure | 3 (27.2%) | 2 (0.9%) | 2 (28.5%) | 1 (0.8%) | <0.0001 |
Others | 0 (0%) | 6 (5.5%) | 0 (0%) | 2 (1.6%) | 0.315 |
Abbreviations: CPFE, combined pulmonary fibrosis and emphysema; IP, interstitial pneumonia; ALI, acute lung injury; mech vent, mechanical ventilation; HOT, home oxygen therapy.